Gene · 100302142
Papers2,664
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,664
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-1246 regulates odontogenic differentiation of human dental pulp stem cells in an inflammatory microenvironment by targeting AXIN2: an in vitro study. | Acta Odontol Scand | 2026 | 42752890 | PubTator, text mining | PubMed |
| The Acidic Exosomal miR-1246/WASF3 Axis Regulates Hepatic Stellate Cell Activation and Stiff ECM Remodeling to Promote Pancreatic Ductal Adenocarcinoma Liver Metastasis. | Int J Biol Sci | 2026 | 42694796 | PubTator, text mining | PubMed |
| CD22+-apoptotic vesicles from cardiac fibroblasts provide endogenous cardioprotection against myocardial ischemia-reperfusion injury. | Sci China Life Sci | 2026 | 42667538 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of circulating microRNAs in dengue infection: biomarkers, pathogenesis, and clinical implications. | Funct Integr Genomics | 2026 | 42645575 | PubTator, text mining | PubMed |
| miR-1246 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Breast Cancer: A Narrative Review With Pharmacoeconomic Perspectives. | Health Sci Rep | 2026 | 42609748 | PubTator, text mining | PubMed |
| Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification. | Eur J Cancer | 2026 | 42594670 | PubTator, text mining | PubMed |
| RETRACTED: Lin et al. miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas. Cancers 2018, 10, 272. | Cancers (Basel) | 2026 | 42492012 | PubTator, text mining | PubMed |
| Integrated Low-Speed Isolation and Ultrasensitive In-Situ Detection of Glioblastoma EVs via UiO-66-NH2@Au Nanocomposite with Temperature Synergistic Membrane Fusion and Y-EXPAR Assay. | Anal Chem | 2026 | 42482667 | PubTator, text mining | PubMed |
| Cancer-associated adipocytes confer CDK4/6 inhibitor resistance in ER+ breast cancer through an IL-6/STAT3/SREBF2 axis coupled with cholesterol metabolism and cell cycle reprogramming. | Int J Biol Sci | 2026 | 42328452 | PubTator, text mining | PubMed |
| Altered miRNA cargo of endometrial extracellular vesicles in patients with endometriosis: potential implications for pregnancy outcomes. | Hum Reprod Open | 2026 | 42282918 | PubTator, text mining | PubMed |
| MicroRNAs in Asthma: A Replication-Based Review of Human Evidence. | J Inflamm Res | 2026 | 42232156 | PubTator, text mining | PubMed |
| Exosomal MicroRNAs as Drivers of Desmoplasia and Treatment Resistance in Breast Cancer: Mechanisms, Biomarker Potential, and Therapeutic Opportunities. | Biomolecules | 2026 | 42194032 | PubTator, text mining | PubMed |
| Beyond miRNAs: exploratory profiling of PIWI-interacting RNAs and small nucleolar RNAs in non-small cell lung cancer-related malignant pleural effusions. | Transl Lung Cancer Res | 2026 | 42170264 | PubTator, text mining | PubMed |
| Dental pulp stem cell-derived exosomes attenuate psoriatic inflammation by restoring epithelial redox homeostasis via a miR-1246/miR-17-3p-GPX2-NF-κB axis. | Stem Cell Res Ther | 2026 | 42106764 | PubTator, text mining | PubMed |
| Interpretable miRNA-based prediction model for early detection of pancreatic cancer: Development and cross-platform validation. | PLoS One | 2026 | 42081539 | PubTator, text mining | PubMed |
| Neighborhood socioeconomic deprivation and physical activity associate with extracellular vesicle size and cargo in a community-based cohort of women. | Sci Rep | 2026 | 42049829 | PubTator, text mining | PubMed |
| Exosomal miR-1246 in Syphilis Serofast State: Diagnostic Value and NLRP3 Inflammasome Suppression. | Immun Inflamm Dis | 2026 | 41958142 | PubTator, text mining | PubMed |
| Postoperative exosomal miR-1246 fuels hepatocellular carcinoma metastasis via BMP9-SMAD7 axis suppression. | Cancer Lett | 2026 | 41921855 | PubTator, text mining | PubMed |
| Tumor exosomes impact functional hallmarks of cancer. | Cancer Metastasis Rev | 2026 | 41912733 | PubTator, text mining | PubMed |
| Exosomal Cargo-Derived Mediators of Ovarian Cancer Chemoresistance. | Mol Diagn Ther | 2026 | 41904344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/100302142/papers